Trump met with some of the world’s biggest Big Pharma executives Tuesday of this week. His message was pretty clear: lower drug prices, bring jobs back to the U.S., and he’ll gut the already weakened FDA, doing away with those pesky regulations that barely keep the American people safe now.
Health & Medicine
New findings suggest that copy fees can greatly limit patient access to their medical records. Patients in the US are supposed to be able to easily obtain electronic copies of their medical records, but steep fees make that difficult for many across the nation. So why are there fees in the first place if patients are supposed to be allowed easy access to their records? Well, according to Dr. Harlan Krumholz of the Yale School of Medicine in New Haven, Connecticut, last year new federal guidelines were issued allowing healthcare providers to “charge fees for labor, costs of creating electronic or paper copies of records and postage.”
Even before Donald Trump was elected our nation’s new president, Republicans were calling for a repeal of the Affordable Care Act (ACA), commonly referred to as Obamacare. However, many wonder what kind of plans Republicans have for a replacement. According to President Trump, he wants “insurance for everybody” that “lowers costs and deductibles.” That sounds nice, but how will it be accomplished? After all, Tim Michling, an analyst for the Citizens Research Council of Michigan summed it up nicely when he said, “healthcare is complex and requires trade-offs in terms of how best to use limited resources. It’s time to make some tough decisions.” However, there are many misconceptions about healthcare reform floating around out there that should be addressed before anyone makes any concrete plans for Obamacare reform.
Now that the post-inauguration dust has mostly settled, the new Commander-in-Chief is setting about the task of fulfilling his promise to “Make America Great Again.” One of his targets is Big Pharma and the industry’s fondness for jacking drug prices so high you almost need the Hubble telescope to see them. Of course, the industry is not about to take this without fighting back. Even Martin Shkreli, Big Pharma’s former bad boy, has some things to say about it (and not what you’d expect). I’m glad I’m sitting down to write this because I’m about to say something I never imagined: I agree with both of these gentlemen, Trump and Shkreli, on this issue.
Tom Price, Trump’s pick to lead Health and Human Services, has an ethically questionable investment and legislative history. Just days after purchasing stock in Zimmer Biomet, for example, he turned around and introduced legislation that would significantly benefit this manufacturer of artificial joint replacements by delaying implementation of a Medicare rule to enhance safety and save taxpayer money. Now Trump wants him to lead the department that regulates companies like Zimmer Biomet as well as overseeing Medicare. Our elders deserve better than this.
Massachusetts Supreme Judicial Court refused to outright dismiss the nearly 21,000 drug related criminal cases linked to Annie Dookhan.
Republicans are bound and determined to make changes to the Affordable Healthcare law. Whether those changes entail a complete repeal and replacement or changes to the existing law is yet to be seen. There is one change, however, that many are talking about, and that’s implementing more aggressive malpractice legislation.
A Dallas judge’s ruling resulted in a pyrrhic victory for Johnson & Johnson. The latest and possibly last chapter in a long-lasting court case came to a close at the beginning of January. For two years, Johnson & Johnson had been fighting six plaintiffs’ accusations of negligence. At the forefront of the drama was a
Heart device users beware. The Homeland Security Department and FDA recently issued warnings about a cybersecurity flaw in one of St. Jude’s medical devices, an implantable heart device. The warning was issued upon discovering that hackers could potentially “take control of a person’s defibrillator or pacemaker” remotely. As if that’s not bad enough, this flaw
How much of the price of health care is really what health care costs? That seems like a silly question, but it’s worth asking since it determines how much you end up paying. With medical costs rising, learning how prices are determined is the first step in keeping care affordable. The price of health care,